Technology
Dual Vector Technology
Dual Vector Technology

Dual vector technology
enables Atsena to address diseases associated with mutations in large genes

Our dual vectors are constructed to deliver larger payloads for genetic mutations that are too large to treat with a single AAV vector.

Credit: MoA animation by Visual Science, 2022

Our dual vectors generate normal levels of expression in non-human primate retina

Atsena is leveraging a dual AAV vector approach in a preclinical program for MYO7A-associated Usher Syndrome (USH1B). Because the MYO7A cDNA is too long to fit in a single vector, it is split in half and each half is delivered via a separate AAV vector. Upon co-infection of cells with both vectors, the gene halves recombine to form full length MYO7A.

accessibility optionsAccessibility
Text Size
A
A